Eosinophilic airway disorders

Seminars in Respiratory and Critical Care Medicine

Volumn 27, Issue 2, 2006, Pages 128-133

  Scott, Karen A ^a   Wardlaw, Andrew J ^a,b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

Asthma; Chronic obstructive airways disease; Eosinophilic bronchitis; Eosinophils; Inflammation

Indexed keywords

STEROID;

AIRWAY OBSTRUCTION; BRONCHITIS; BRONCHUS HYPERREACTIVITY; CHRONIC DISEASE; CLINICAL FEATURE; COUGHING; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; EOSINOPHILIA; FORCED EXPIRATORY VOLUME; HUMAN; MAST CELL; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFLAMMATION; REVIEW; SPUTUM ANALYSIS;

ASTHMA; BRONCHITIS; EOSINOPHILIA; EOSINOPHILS; HUMANS; INFLAMMATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY TRACT DISEASES;

EID: 33646452279     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-939515     Document Type: Review

References (38)

1. Pavord ID, Pizzichini MM, Pizzichini E, Hargreave FE. The use of induced sputum to investigate airway inflammation. Thorax 1997;52:498-501
2. Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002;360:1715-1721
3. Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000;105:651-663
4. Tavernier J, Van der HJ, Verhee A, et al. Interleukin 5 regulates the isoform expression of its own receptor alpha-subunit. Blood 2000;95:1600-1607
5. Spry CJF. The natural history of eosinophils. In: Smith H, Cook RM, eds. The immunopharmacology of eosinophils. London: Academic Press; 1993:1-9
6. Kay AB. T cells as orchestrators of the asthmatic response. Ciba Found Symp 1997;206:56-67
7. Leckie MJ, Brinke AT, Khan J, et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000;356:2144-2148
8. Domachowske JB, Bonville CA, Easton AJ, Rosenberg HF. Pulmonary eosinophilia in mice devoid of interleukin-5. J Leukoc Biol 2002;71:966-972
9. Giembycz MA, Lindsay MA. Pharmacology of the eosinophil. Pharmacol Rev 1999;51:213-340
10. Wardlaw AJ. Molecular basis for selective eosinophil trafficking in asthma: a multistep paradigm. J Allergy Clin Immunol 1999;104:917-926
11. Bochner BS. Road signs guiding leukocytes along the inflammation superhighway. J Allergy Clin Immunol 2000; 106:817-828
12. Kita H, Weiler DA, bu-Ghazaleh R, Sanderson CJ, Gleich GJ. Release of granule proteins from eosinophils cultured with IL-5. J Immunol 1992;149:629-635
13. Nicklas RA. National and international guidelines for the diagnosis and treatment of asthma. Curr Opin Pulm Med 1997;3:51-55
14. Sidebotham HJ, Roche WR. Asthma deaths; persistent and preventable mortality. Histopathology 2003;43:105-117
15. Chapman ID, Foster A, Morley J. The relationship between inflammation and hyperreactivity of the airways in asthma. Clin Exp Allergy 1993;23:168-171
16. Wardlaw AJ, Brightling C, Green R, Woltmann G, Pavord I. Eosinophils in asthma and other allergic diseases. Br Med Bull 2000;56:985-1003
17. Green RH, Brightling CE, Woltmann G, Parker D, Wardlaw AJ, Pavord ID. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 2002;57:875-879
18. Flood-Page PT, Menzies-Gow AN, Kay AB, Robinson DS. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med 2003;167:199-204
19. Wenzel SE, Schwartz LB, Langmack EL, et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999;160:1001-1008
20. Gibson PG, Simpson JL, Saltos N. Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 2001; 119:1329-1336
21. Brightling CE, Monteiro W, Ward R, et al. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2000;356:1480-1485
22. Gibson PG, Dolovich J, Denburg J, Ramsdale EH, Hargreave FE. Chronic cough: eosinophilic bronchitis without asthma. Lancet 1989;1:1346-1348
23. Brightling CE, Ward R, Goh KL, Wardlaw AJ, Pavord ID. Eosinophilic bronchitis is an important cause of chronic cough. Am J Respir Crit Care Med 1999;160: 406-410
24. Berry MA, Hargadon B, McKenna S, et al. Observational study of the natural history of eosinophilic bronchitis. Clin Exp Allergy 2005;35:598-601
25. Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002;346:1699-1705
26. Brightling CE, Symon FA, Birring SS, Bradding P, Pavord ID, Wardlaw AJ. TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis. J Allergy Clin Immunol 2002;110:899-905
27. Ronchi MC, Piragino C, Rosi E, Amendola M, Duranti R, Scano G. Role of sputum differential cell count in detecting airway inflammation in patients with chronic bronchial asthma or COPD. Thorax 1996;51:1000-1004
28. Balzano G, Stefanelli F, Iorio C, et al. Eosinophilic inflammation in stable chronic obstructive pulmonary disease. Relationship with neutrophils and airway function. Am J Respir Crit Care Med 1999;160:1486-1492
29. Jeffery PK. Differences and similarities between chronic obstructive pulmonary disease and asthma. Clin Exp Allergy 1999;29(Suppl 2):14-26
30. Saetta M, Di SA, Maestrelli P, et al. Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis. Clin Exp Allergy 1996; 26:766-774
31. Papi A, Romagnoli M, Baraldo S, et al. Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;162:1773-1777
32. Dippolito R, Foresi A, Chetta A, et al. Eosinophils in induced sputum from asymptomatic smokers with normal lung function. Respir Med 2001;95:969-974
33. Saetta M, Di SA, Maestrelli P, et al. Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med 1994;150:1646-1652
34. Saetta M, Di SA, Turato G, et al. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157: 822-826
35. Lams BE, Sousa AR, Rees PJ, Lee TH. Immunopathology of the small-airway submucosa in smokers with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:1518-1523
36. Sutherland ER, Allmers H, Ayas NT, Venn AJ, Martin RJ. Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis. Thorax 2003;58:937-941
37. Fujimoto K, Kubo K, Yamamoto H, Yamaguchi S, Matsuzawa Y. Eosinophilic inflammation in the airway is related to glucocorticoid reversibility in patients with pulmonary emphysema. Chest 1999;115:697-702
38. Brightling CE, McKenna S, Hargadon B, et al. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. Thorax 2005;60:193-198